Hyperspectral imaging in automated digital dermoscopy screening for melanoma

Anna Marie Hosking, Brandon J. Coakley, Dorothy Chang, Faezeh Talebi-Liasi, Samantha Lish, Sung Won Lee, Amanda M. Zong, Ian Moore, James Browning, Steven Jacques, James G. Krueger, Kristen M. Kelly, Kenneth G. Linden, Daniel S. Gareau

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: Early melanoma detection decreases morbidity and mortality. Early detection classically involves dermoscopy to identify suspicious lesions for which biopsy is indicated. Biopsy and histological examination then diagnose benign nevi, atypical nevi, or cancerous growths. With current methods, a considerable number of unnecessary biopsies are performed as only 11% of all biopsied, suspicious lesions are actually melanomas. Thus, there is a need for more advanced noninvasive diagnostics to guide the decision of whether or not to biopsy. Artificial intelligence can generate screening algorithms that transform a set of imaging biomarkers into a risk score that can be used to classify a lesion as a melanoma or a nevus by comparing the score to a classification threshold. Melanoma imaging biomarkers have been shown to be spectrally dependent in Red, Green, Blue (RGB) color channels, and hyperspectral imaging may further enhance diagnostic power. The purpose of this study was to use the same melanoma imaging biomarkers previously described, but over a wider range of wavelengths to determine if, in combination with machine learning algorithms, this could result in enhanced melanoma detection. Methods: We used the melanoma advanced imaging dermatoscope (mAID) to image pigmented lesions assessed by dermatologists as requiring a biopsy. The mAID is a 21-wavelength imaging device in the 350–950 nm range. We then generated imaging biomarkers from these hyperspectral dermoscopy images, and, with the help of artificial intelligence algorithms, generated a melanoma Q-score for each lesion (0 = nevus, 1 = melanoma). The Q-score was then compared to the histopathologic diagnosis. Results: The overall sensitivity and specificity of hyperspectral dermoscopy in detecting melanoma when evaluated in a set of lesions selected by dermatologists as requiring biopsy was 100% and 36%, respectively. Conclusion: With widespread application, and if validated in larger clinical trials, this non-invasive methodology could decrease unnecessary biopsies and potentially increase life-saving early detection events. Lasers Surg. Med. 9999:XX–XX, 2019.

Original languageEnglish (US)
JournalLasers in Surgery and Medicine
DOIs
StateAccepted/In press - Jan 1 2019
Externally publishedYes

Fingerprint

Dermoscopy
Melanoma
Biopsy
Nevus
Biomarkers
Artificial Intelligence
Nevi and Melanomas
Lasers
Color
Clinical Trials

Keywords

  • artificial intelligence
  • dermoscopy
  • hyperspectral imaging
  • machine learning
  • melanoma

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Hosking, A. M., Coakley, B. J., Chang, D., Talebi-Liasi, F., Lish, S., Lee, S. W., ... Gareau, D. S. (Accepted/In press). Hyperspectral imaging in automated digital dermoscopy screening for melanoma. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23055

Hyperspectral imaging in automated digital dermoscopy screening for melanoma. / Hosking, Anna Marie; Coakley, Brandon J.; Chang, Dorothy; Talebi-Liasi, Faezeh; Lish, Samantha; Lee, Sung Won; Zong, Amanda M.; Moore, Ian; Browning, James; Jacques, Steven; Krueger, James G.; Kelly, Kristen M.; Linden, Kenneth G.; Gareau, Daniel S.

In: Lasers in Surgery and Medicine, 01.01.2019.

Research output: Contribution to journalArticle

Hosking, AM, Coakley, BJ, Chang, D, Talebi-Liasi, F, Lish, S, Lee, SW, Zong, AM, Moore, I, Browning, J, Jacques, S, Krueger, JG, Kelly, KM, Linden, KG & Gareau, DS 2019, 'Hyperspectral imaging in automated digital dermoscopy screening for melanoma', Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23055
Hosking, Anna Marie ; Coakley, Brandon J. ; Chang, Dorothy ; Talebi-Liasi, Faezeh ; Lish, Samantha ; Lee, Sung Won ; Zong, Amanda M. ; Moore, Ian ; Browning, James ; Jacques, Steven ; Krueger, James G. ; Kelly, Kristen M. ; Linden, Kenneth G. ; Gareau, Daniel S. / Hyperspectral imaging in automated digital dermoscopy screening for melanoma. In: Lasers in Surgery and Medicine. 2019.
@article{d131bdcb05664e899882cd77158e072b,
title = "Hyperspectral imaging in automated digital dermoscopy screening for melanoma",
abstract = "Objectives: Early melanoma detection decreases morbidity and mortality. Early detection classically involves dermoscopy to identify suspicious lesions for which biopsy is indicated. Biopsy and histological examination then diagnose benign nevi, atypical nevi, or cancerous growths. With current methods, a considerable number of unnecessary biopsies are performed as only 11{\%} of all biopsied, suspicious lesions are actually melanomas. Thus, there is a need for more advanced noninvasive diagnostics to guide the decision of whether or not to biopsy. Artificial intelligence can generate screening algorithms that transform a set of imaging biomarkers into a risk score that can be used to classify a lesion as a melanoma or a nevus by comparing the score to a classification threshold. Melanoma imaging biomarkers have been shown to be spectrally dependent in Red, Green, Blue (RGB) color channels, and hyperspectral imaging may further enhance diagnostic power. The purpose of this study was to use the same melanoma imaging biomarkers previously described, but over a wider range of wavelengths to determine if, in combination with machine learning algorithms, this could result in enhanced melanoma detection. Methods: We used the melanoma advanced imaging dermatoscope (mAID) to image pigmented lesions assessed by dermatologists as requiring a biopsy. The mAID is a 21-wavelength imaging device in the 350–950 nm range. We then generated imaging biomarkers from these hyperspectral dermoscopy images, and, with the help of artificial intelligence algorithms, generated a melanoma Q-score for each lesion (0 = nevus, 1 = melanoma). The Q-score was then compared to the histopathologic diagnosis. Results: The overall sensitivity and specificity of hyperspectral dermoscopy in detecting melanoma when evaluated in a set of lesions selected by dermatologists as requiring biopsy was 100{\%} and 36{\%}, respectively. Conclusion: With widespread application, and if validated in larger clinical trials, this non-invasive methodology could decrease unnecessary biopsies and potentially increase life-saving early detection events. Lasers Surg. Med. 9999:XX–XX, 2019.",
keywords = "artificial intelligence, dermoscopy, hyperspectral imaging, machine learning, melanoma",
author = "Hosking, {Anna Marie} and Coakley, {Brandon J.} and Dorothy Chang and Faezeh Talebi-Liasi and Samantha Lish and Lee, {Sung Won} and Zong, {Amanda M.} and Ian Moore and James Browning and Steven Jacques and Krueger, {James G.} and Kelly, {Kristen M.} and Linden, {Kenneth G.} and Gareau, {Daniel S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/lsm.23055",
language = "English (US)",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Hyperspectral imaging in automated digital dermoscopy screening for melanoma

AU - Hosking, Anna Marie

AU - Coakley, Brandon J.

AU - Chang, Dorothy

AU - Talebi-Liasi, Faezeh

AU - Lish, Samantha

AU - Lee, Sung Won

AU - Zong, Amanda M.

AU - Moore, Ian

AU - Browning, James

AU - Jacques, Steven

AU - Krueger, James G.

AU - Kelly, Kristen M.

AU - Linden, Kenneth G.

AU - Gareau, Daniel S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: Early melanoma detection decreases morbidity and mortality. Early detection classically involves dermoscopy to identify suspicious lesions for which biopsy is indicated. Biopsy and histological examination then diagnose benign nevi, atypical nevi, or cancerous growths. With current methods, a considerable number of unnecessary biopsies are performed as only 11% of all biopsied, suspicious lesions are actually melanomas. Thus, there is a need for more advanced noninvasive diagnostics to guide the decision of whether or not to biopsy. Artificial intelligence can generate screening algorithms that transform a set of imaging biomarkers into a risk score that can be used to classify a lesion as a melanoma or a nevus by comparing the score to a classification threshold. Melanoma imaging biomarkers have been shown to be spectrally dependent in Red, Green, Blue (RGB) color channels, and hyperspectral imaging may further enhance diagnostic power. The purpose of this study was to use the same melanoma imaging biomarkers previously described, but over a wider range of wavelengths to determine if, in combination with machine learning algorithms, this could result in enhanced melanoma detection. Methods: We used the melanoma advanced imaging dermatoscope (mAID) to image pigmented lesions assessed by dermatologists as requiring a biopsy. The mAID is a 21-wavelength imaging device in the 350–950 nm range. We then generated imaging biomarkers from these hyperspectral dermoscopy images, and, with the help of artificial intelligence algorithms, generated a melanoma Q-score for each lesion (0 = nevus, 1 = melanoma). The Q-score was then compared to the histopathologic diagnosis. Results: The overall sensitivity and specificity of hyperspectral dermoscopy in detecting melanoma when evaluated in a set of lesions selected by dermatologists as requiring biopsy was 100% and 36%, respectively. Conclusion: With widespread application, and if validated in larger clinical trials, this non-invasive methodology could decrease unnecessary biopsies and potentially increase life-saving early detection events. Lasers Surg. Med. 9999:XX–XX, 2019.

AB - Objectives: Early melanoma detection decreases morbidity and mortality. Early detection classically involves dermoscopy to identify suspicious lesions for which biopsy is indicated. Biopsy and histological examination then diagnose benign nevi, atypical nevi, or cancerous growths. With current methods, a considerable number of unnecessary biopsies are performed as only 11% of all biopsied, suspicious lesions are actually melanomas. Thus, there is a need for more advanced noninvasive diagnostics to guide the decision of whether or not to biopsy. Artificial intelligence can generate screening algorithms that transform a set of imaging biomarkers into a risk score that can be used to classify a lesion as a melanoma or a nevus by comparing the score to a classification threshold. Melanoma imaging biomarkers have been shown to be spectrally dependent in Red, Green, Blue (RGB) color channels, and hyperspectral imaging may further enhance diagnostic power. The purpose of this study was to use the same melanoma imaging biomarkers previously described, but over a wider range of wavelengths to determine if, in combination with machine learning algorithms, this could result in enhanced melanoma detection. Methods: We used the melanoma advanced imaging dermatoscope (mAID) to image pigmented lesions assessed by dermatologists as requiring a biopsy. The mAID is a 21-wavelength imaging device in the 350–950 nm range. We then generated imaging biomarkers from these hyperspectral dermoscopy images, and, with the help of artificial intelligence algorithms, generated a melanoma Q-score for each lesion (0 = nevus, 1 = melanoma). The Q-score was then compared to the histopathologic diagnosis. Results: The overall sensitivity and specificity of hyperspectral dermoscopy in detecting melanoma when evaluated in a set of lesions selected by dermatologists as requiring biopsy was 100% and 36%, respectively. Conclusion: With widespread application, and if validated in larger clinical trials, this non-invasive methodology could decrease unnecessary biopsies and potentially increase life-saving early detection events. Lasers Surg. Med. 9999:XX–XX, 2019.

KW - artificial intelligence

KW - dermoscopy

KW - hyperspectral imaging

KW - machine learning

KW - melanoma

UR - http://www.scopus.com/inward/record.url?scp=85060221502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060221502&partnerID=8YFLogxK

U2 - 10.1002/lsm.23055

DO - 10.1002/lsm.23055

M3 - Article

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

ER -